As of 12:44pm ET
| -0.005 / -0.32%|
The 1 analysts offering 12-month price forecasts for Prima BioMed Ltd have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +353.08% increase from the last price of 1.55.
The current consensus among 1 polled investment analysts is to Buy stock in Prima BioMed Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.